LBT-3393

N/A

Report date: 2024/09/24 13:52:43
NME

Base Information

Drug NameLBT-3393
Drug Alias NameLBT-3393
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionVasoactive intestinal polypeptide receptor 1 agonists
TargetsVasoactive intestinal polypeptide receptor 1
Therapy Area/IndicationsColitis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLongevity Biotech Australia Pty Ltd
China Registration ClassN/A

Develop Information

Active CompaniesLongevity Biotech Australia Pty Ltd
Inactive CompaniesN/A
Active IndicationsColitis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A